Evaluation of Neonatal Hemolytic Jaundice: Clinical and Laboratory Parameters
DOI:
https://doi.org/10.3889/oamjms.2015.129Keywords:
hemolytic jaundice, ABO/Rh isoimmunisation, unspecific etiology, laboratoryAbstract
BACKGROUND: Neonatal jaundice that occurs in ABO or Rhesus issoimunisation has been recognized as one of the major risk factors for development of severe hyperbilirubinemia and bilirubin neurotoxicity.
AIM: Aim of our study was to investigate clinical and laboratory parameters associated with hemolytic jaundice due to Rh and ABO incompatibility and compare results with the group of unspecific jaundice.
MATERIAL AND METHODS: One hundred sixty seven (167) neonatal hyperbilirubinemia cases were included in the study, 24.6% of which presented with ABO/Rhesus type hemolytic jaundice, and the rest with unspecific jaundice. Evaluation included: blood count, reticulocites, serum bilirubin, aminotransferases, blood grouping, and Coombs test, also the day of bilirubin peak, duration of the hyperbilirubinemia, and additional bilirubin measurements.
RESULTS: We showed significantly lower mean values of hemoglobin, erythrocytes and hematocrit and significantly higher values of reticulocytes in the group of ABO/Rh incompatibility compared to the group of jaundice of unspecific etiology; also an earlier presentation and a higher-grade jaundice in this group.
CONCLUSIONS: The laboratory profile in ABO/Rh isoimmunisation cases depicts hemolytic mechanism of jaundice. These cases carry a significant risk for early and severe hyperbilirubinemia and are eligible for neurodevelopmental follow-up. Hematological parameters and blood grouping are simple diagnostic methods that assist the etiological diagnosis of neonatal hyperbilirubinemia.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Detection and treatment of neonatal jaundice-NICE guideline. Lancet. 2010;29:375(9729)-1845. DOI: https://doi.org/10.1016/S0140-6736(10)60852-5
Porter ML, and Dennis BL. Hyperbilirubinemia in the term newborn. Am Fam Physician. 2002;65(4):599-607.
PMid:11871676
Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med. 2001;344(8):581-90.
http://dx.doi.org/10.1056/NEJM200102223440807 DOI: https://doi.org/10.1056/NEJM200102223440807
PMid:11207355
Kaplan M, Muraca M, Hammerman C, et al. Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice. Pediatrics. 2002;110(4):e47.
http://dx.doi.org/10.1542/peds.110.4.e47 DOI: https://doi.org/10.1542/peds.110.4.e47
PMid:12359820
Watchko JF, Daood MJ, Biniwale M. Understanding neonatal hyperbilirubinemia in the era of genomics. Semin Neonatol. 2002;7(2):143–52.
http://dx.doi.org/10.1053/siny.2002.0102 DOI: https://doi.org/10.1053/siny.2002.0102
PMid:12208099
Kaplan M, Hammerman C, Maisels MJ. Bilirubin genetics for the nongeneticist: hereditary defects of neonatal bilirubin conjugation. Pediatrics. 2003;111(4):886–93.
http://dx.doi.org/10.1542/peds.111.4.886 DOI: https://doi.org/10.1542/peds.111.4.886
PMid:12671128
Watchko JF, Lin Z, Clark RH, et al. Complex multifactorial nature of significant hyperbilirubinemia in neonates. Pediatrics. 2009;124(5):e868-77.
http://dx.doi.org/10.1542/peds.2009-0460 DOI: https://doi.org/10.1542/peds.2009-0460
PMid:19858149
Lin Z, Fontaine J and Watchko JF. Coexpression of gene polymorphisms involved in bilirubin production and metabolism. Pediatrics. 2008;122(1):e156-62.
http://dx.doi.org/10.1542/peds.2007-3249 DOI: https://doi.org/10.1542/peds.2007-3249
PMid:18558634
American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316.
http://dx.doi.org/10.1542/peds.114.1.297 DOI: https://doi.org/10.1542/peds.114.1.297
Maisels MJ, Bhutani VK, Bogen D, et al. Hyperbilirubinemia in the newborn infant > or =35 weeks' gestation: an update with clarifications. Pediatrics. 2009;124(4):1193-8.
http://dx.doi.org/10.1542/peds.2009-0329 DOI: https://doi.org/10.1542/peds.2009-0329
PMid:19786452
Bhutani VK, Johnson LH, Maisels MJ, et al. Kernicterus: epidemiologic strategies for its prevention through systems-based approaches. J Perinatol. 2004;24(10):650–62.
http://dx.doi.org/10.1038/sj.jp.7211152 DOI: https://doi.org/10.1038/sj.jp.7211152
PMid:15254556
Papazovska Cherepnalkovski A, Piperkova K, Palcevska Kocevska S, et al. Evaluation and management of neonatal indirect hyperbilirubinemia at the University Pediatric Clinic in Skopje, Republic of Macedonia Medicus. 2015;20(2):221–29.
Koosha A, Rafizadeh B. Evaluation of neonatal indirect hyperbilirubinaemia at Zanjan Province of Iran in 2001-2003: prevalence of glucose-6-phosphate dehydrogenase deficiency. Singapore Med J. 2007;48(5):424-8.
PMid:17453100
Curme H, Rand RN. Early history of Eastman Kodak Ektachem slides and instrumentation. Clinical Chemistry. 1997;43(9):1647-52. DOI: https://doi.org/10.1093/clinchem/43.9.1647
PMid:9299947
Krzelj V, Zlodre S, Terzic J, et al. Prevalence of G-6-PD deficiency in the Croatian Adriatic Coast population. Arch Med Res. 2001;32:454-7.
http://dx.doi.org/10.1016/S0188-4409(01)00301-0 DOI: https://doi.org/10.1016/S0188-4409(01)00301-0
Beutler E, Blume KG, Kaplan JC, et al. International Committee for standardization in haematology: recommended methods for red cell enzyme analysis. Br J Haematol. 1977;35:331-40.
http://dx.doi.org/10.1111/j.1365-2141.1977.tb00589.x DOI: https://doi.org/10.1111/j.1365-2141.1977.tb00589.x
PMid:857853
Alkalay AL, Simmons CF. Hyperbilirubinemia guidelines in newborn infants. Pediatrics. 2005;115(3):824-5.
http://dx.doi.org/10.1542/peds.2004-2442 DOI: https://doi.org/10.1542/peds.2004-2442
PMid:15741399
Bratlid D, Nakstad B, Hansen TW. National guidelines for treatment of jaundice in the newborn. Acta Paediatr. 2011;100(4):499-505.
http://dx.doi.org/10.1111/j.1651-2227.2010.02104.x DOI: https://doi.org/10.1111/j.1651-2227.2010.02104.x
PMid:21114525
Beeby P, Evans N. Jaundice. Royal Prince Alfred Hospital Web site. RPA Newborn Care Guidelines. http://www.slhd.nsw.gov.au/rpa/neonatal%5Ccontent/pdf/guidelines/jaundice.pdf. Accessed October 29, 2015.
Maisels MJ, McDonagh AF. Phototherapy for Neonatal Jaundice. N Engl J Med. 2008;358:920-28.
http://dx.doi.org/10.1056/NEJMct0708376 DOI: https://doi.org/10.1056/NEJMct0708376
PMid:18305267
Rennie JM, Sehgal A, De A, Kendall GS, Cole TJ. Range of UK practice regarding thresholds for phototherapy and exchange transfusion in neonatal hyperbilirubinaemia. Arch Dis Child Fetal Neonatal Ed. 2009;94:F323–7.
http://dx.doi.org/10.1136/adc.2008.147686 DOI: https://doi.org/10.1136/adc.2008.147686
PMid:19000996
Kaplan M, Bromiker R, Hammerman C. Hyperbilirubinemia, hemolysis, and increased bilirubin neurotoxicity. Semin Perinatol. 2014;38(7):429-37.
http://dx.doi.org/10.1053/j.semperi.2014.08.006 DOI: https://doi.org/10.1053/j.semperi.2014.08.006
PMid:25284470
Tiker F, Gulcan H, Kilicdag H, Tarcan A, Gurakan B. Extreme hyperbilirubinemia in newborn infants. Clin Pediatr (Phila). 2006;45(3):257-61.
http://dx.doi.org/10.1177/000992280604500308 DOI: https://doi.org/10.1177/000992280604500308
Davutoğlu M, Garipardiç M, Güler E, Karabiber H, Erhan D. The etiology of severe neonatal hyperbilirubinemia and complications of exchange transfusion. Turk J Pediatr. 2010;52(2):163-6.
PMid:20560252
Hakan N, Zenciroglu A, Aydin M, et al. Exchange transfusion for neonatal hyperbilirubinemia: an 8-year single center experience at a tertiary neonatal intensive care unit in Turkey. J Matern Fetal Neonatal Med. 2014;22:1-5. DOI: https://doi.org/10.3109/14767058.2014.960832
Kaplan M, Hammerman C. Severe neonatal hyperbilirubinemia, a potential complication of glucose-6-phosphate dehydrogenase deficiency. Current Controversies in Perinatal Care III. 1998;25(3):575-90. DOI: https://doi.org/10.1016/S0095-5108(18)30098-8
Kaplan M, Muraca M, Hammerman C, et al. Bilirubin conjugation, reflected by conjugated bilirubin fractions, in glucose-6-phosphate dehydrogenase-deficient neonates: a determining factor in the pathogenesis of hyperbilirubinemia. Pediatrics. 1998;102:E37.
http://dx.doi.org/10.1542/peds.102.3.e37 DOI: https://doi.org/10.1542/peds.102.3.e37
PMid:9724685
Mishra JP, Mishra J, Padhi RK, Mishra S, Manjareeka M. Hematological profile in neonatal jaundice. J Basic Clin Physiol Pharmacol. 2014;25(2):225-8.
http://dx.doi.org/10.1515/jbcpp-2013-0087 DOI: https://doi.org/10.1515/jbcpp-2013-0087
PMid:24114906
Ip S, Chung M, Kulig J, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004;114(1):e130-53.
http://dx.doi.org/10.1542/peds.114.1.e130 DOI: https://doi.org/10.1542/peds.114.1.e130
PMid:15231986
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0